Cisplatin 50mg/50mL Injection

Cisplatin 50mg/50mL is a platinum chemotherapy used in treatment regimens for cancers such as testicular, ovarian and bladder cancer. It may be combined with other anticancer medicines or radiotherapy according to the tumour being treated.
The diluted medicine is infused into a vein in a chemotherapy unit. Intravenous fluids are given before and after treatment to protect the kidneys, and anti-sickness medicines are usually provided. The dose and cycle interval depend on body size, the regimen and laboratory results.
Cisplatin binds to DNA and creates cross-links that prevent DNA copying and repair. This disrupts division of rapidly growing cancer cells and promotes cell death.
Nausea, vomiting, taste changes, reduced blood counts and fatigue can occur. Important toxicities include kidney injury, hearing loss, ringing in the ears and peripheral neuropathy. Reduced urine, severe dizziness or a new hearing change needs prompt assessment.
Kidney function, magnesium, potassium, blood counts and hearing are assessed during treatment. Dehydration and other kidney-toxic or hearing-toxic medicines can increase harm. Fever during a low blood-count period can be a sign of a serious infection.
Cisplatin is a key component of several effective cancer regimens, including potentially curative testicular-cancer treatment. In other settings, it can shrink disease or improve tumour control alongside surgery or radiotherapy.
Cisplatin can injure kidney tubules. Hydration and adequate urine flow help reduce exposure of the kidneys to the drug; the fluid plan is tailored to heart and kidney function.
No. Tinnitus or a change in hearing can be an early sign of ototoxicity. Report it promptly because further exposure may worsen the problem.
Cisplatin can make the kidneys lose these electrolytes. Low levels can contribute to cramps, weakness and heart-rhythm problems and may need replacement.
Yes. Cisplatin can cause delayed nausea and vomiting over the following days. The take-home antiemetic schedule covers this delayed phase, not just symptoms during infusion.
DNA cross-link: chemical bond interfering with DNA function. Nephrotoxicity: kidney injury caused by a substance. Ototoxicity: damage affecting hearing or balance. Electrolytes: minerals required for nerve, muscle and heart function. Antiemetic: medicine preventing nausea and vomiting.; AR: Cisplatin 50mg/50mL حقن; FR: Cisplatin 50mg/50mL préparation injectable; PT: Cisplatin 50mg/50mL injetável; ES: Cisplatin 50mg/50mL inyectable; RU: Cisplatin 50mg/50mL инъекционная форма; ID: Cisplatin 50mg/50mL injeksi; VI: Cisplatin 50mg/50mL thuốc tiêm; MS: Cisplatin 50mg/50mL suntikan; TL: Cisplatin 50mg/50mL iniksyon; ZH-SG: Cisplatin 50mg/50mL 注射剂
International B2B Enquiry
Send a structured B2B enquiry for Cisplatin 50mg/50mL Injection under Oncology Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Cisplatin 50mg/50mL Injection